Using in silico analysis of the TCGA database, we found that lung adenocarcinoma patients bearing wild-type EGFR with the higher FGFR4 expression level is correlated with poor overall survival rates and five-years survival rates compared with those with lower FGFR4 expression patients. Here, EGFR is linked to lung adenocarcinoma.